Global Chlorhexidine Gluconate

Chlorhexidine Gluconate Comprehensive Study by Type (CHG 2% Solution, CHG 4% Solution, CHG 20% Solution, CHG 0.12% Solution, Others), Application (Skin Preparation, Surgical Preparation, Pharmaceutical Product, Cosmetics Additive, Others), Form (Water Soluble (Digluconate, Acetate), Sparingly Soluble(Hydrochloride)), Dosage Forms (Mucous membrane insert (2.5 mg), Mucous membrane liquid (0.12%)) Players and Region - Global Market Outlook to 2026

Chlorhexidine Gluconate Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Chlorhexidine Gluconate Market?

Over the years, the chemical has seen a growth in usage and continues to render its uses in the pharma sector. Especially, in the current times of viruses and the pandemic, the demand is at an all-time high. Chlorhexidine gluconate is second generation chemical plaque control agent highly bacteriostatic in nature and is also used as antiseptic in various specialities and is available in different forms for use. It is widely used. It is used individually and also popularly in medical devices. The attributes of this solution that compels people to use it are its effectiveness against fighting micro-bacterial elements. Also, it possesses the quality of being very sensitive and non-irritant to the skin. The chemical tends to lock itself with the skin, thus amplifying its effectiveness.

The market study is being classified by Type (CHG 2% Solution, CHG 4% Solution, CHG 20% Solution, CHG 0.12% Solution and Others), by Application (Skin Preparation, Surgical Preparation, Pharmaceutical Product, Cosmetics Additive and Others) and major geographies with country level break-up.

Xttrium Laboratories (United States), Medichem (South Africa), The Clorox Company (United States), Becton Dickinson Co(United States), Bajaj Medical (United States), MölnlyckeHealth Care (Sweden), 3M (United States), Ecolab (United States), Sage Prods (United States) and STERIS (Ireland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Dharma Research (United States).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Chlorhexidine Gluconate market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Chlorhexidine Gluconate market by Type, Application and Region.

On the basis of geography, the market of Chlorhexidine Gluconate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The chlorhexidine gluconate is used in preoperational procedures to clean the skin and make it germ-free to ease the surgical procedure. The different advantages of chlorhexidine gluconate (CHG) cloths have increased the demand for these products globally
  • Increasing concern towards oral hygiene

Market Trend
  • The growing economies are anticipated to boost the market growth of hospitals and retail pharmacies in developing regions during the assessment period

Restraints
  • Chlorhexidine gluconate can cause a rare but serious allergic reaction that may be life-threatening

Opportunities
  • The rising number of hospital-acquired infections (HAI), an increasing number of surgical procedures & surgical site infections and the growing geriatric population have led to the growth of the global





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Chlorhexidine Gluconate Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Report Objectives / Segmentation Covered

By Type
  • CHG 2% Solution
  • CHG 4% Solution
  • CHG 20% Solution
  • CHG 0.12% Solution
  • Others
By Application
  • Skin Preparation
  • Surgical Preparation
  • Pharmaceutical Product
  • Cosmetics Additive
  • Others
By Form
  • Water Soluble (Digluconate, Acetate)
  • Sparingly Soluble(Hydrochloride)

By Dosage Forms
  • Mucous membrane insert (2.5 mg)
  • Mucous membrane liquid (0.12%)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The chlorhexidine gluconate is used in preoperational procedures to clean the skin and make it germ-free to ease the surgical procedure. The different advantages of chlorhexidine gluconate (CHG) cloths have increased the demand for these products globally
      • 3.2.2. Increasing concern towards oral hygiene
    • 3.3. Market Trends
      • 3.3.1. The growing economies are anticipated to boost the market growth of hospitals and retail pharmacies in developing regions during the assessment period
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Chlorhexidine Gluconate, by Type, Application, Form, Dosage Forms and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Chlorhexidine Gluconate (Value)
      • 5.2.1. Global Chlorhexidine Gluconate by: Type (Value)
        • 5.2.1.1. CHG 2% Solution
        • 5.2.1.2. CHG 4% Solution
        • 5.2.1.3. CHG 20% Solution
        • 5.2.1.4. CHG 0.12% Solution
        • 5.2.1.5. Others
      • 5.2.2. Global Chlorhexidine Gluconate by: Application (Value)
        • 5.2.2.1. Skin Preparation
        • 5.2.2.2. Surgical Preparation
        • 5.2.2.3. Pharmaceutical Product
        • 5.2.2.4. Cosmetics Additive
        • 5.2.2.5. Others
      • 5.2.3. Global Chlorhexidine Gluconate by: Form (Value)
        • 5.2.3.1. Water Soluble (Digluconate, Acetate)
        • 5.2.3.2. Sparingly Soluble(Hydrochloride)
      • 5.2.4. Global Chlorhexidine Gluconate by: Dosage Forms (Value)
        • 5.2.4.1. Mucous membrane insert (2.5 mg)
        • 5.2.4.2. Mucous membrane liquid (0.12%)
      • 5.2.5. Global Chlorhexidine Gluconate Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Chlorhexidine Gluconate (Price)
      • 5.3.1. Global Chlorhexidine Gluconate by: Type (Price)
  • 6. Chlorhexidine Gluconate: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Xttrium Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medichem (South Africa)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. The Clorox Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton Dickinson Co(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bajaj Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. MölnlyckeHealth Care (Sweden)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. 3M (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ecolab (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sage Prods (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. STERIS (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Chlorhexidine Gluconate Sale, by Type, Application, Form, Dosage Forms and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Chlorhexidine Gluconate (Value)
      • 7.2.1. Global Chlorhexidine Gluconate by: Type (Value)
        • 7.2.1.1. CHG 2% Solution
        • 7.2.1.2. CHG 4% Solution
        • 7.2.1.3. CHG 20% Solution
        • 7.2.1.4. CHG 0.12% Solution
        • 7.2.1.5. Others
      • 7.2.2. Global Chlorhexidine Gluconate by: Application (Value)
        • 7.2.2.1. Skin Preparation
        • 7.2.2.2. Surgical Preparation
        • 7.2.2.3. Pharmaceutical Product
        • 7.2.2.4. Cosmetics Additive
        • 7.2.2.5. Others
      • 7.2.3. Global Chlorhexidine Gluconate by: Form (Value)
        • 7.2.3.1. Water Soluble (Digluconate, Acetate)
        • 7.2.3.2. Sparingly Soluble(Hydrochloride)
      • 7.2.4. Global Chlorhexidine Gluconate by: Dosage Forms (Value)
        • 7.2.4.1. Mucous membrane insert (2.5 mg)
        • 7.2.4.2. Mucous membrane liquid (0.12%)
      • 7.2.5. Global Chlorhexidine Gluconate Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Chlorhexidine Gluconate (Price)
      • 7.3.1. Global Chlorhexidine Gluconate by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Chlorhexidine Gluconate: by Type(USD Million)
  • Table 2. Chlorhexidine Gluconate CHG 2% Solution , by Region USD Million (2015-2020)
  • Table 3. Chlorhexidine Gluconate CHG 4% Solution , by Region USD Million (2015-2020)
  • Table 4. Chlorhexidine Gluconate CHG 20% Solution , by Region USD Million (2015-2020)
  • Table 5. Chlorhexidine Gluconate CHG 0.12% Solution , by Region USD Million (2015-2020)
  • Table 6. Chlorhexidine Gluconate Others , by Region USD Million (2015-2020)
  • Table 7. Chlorhexidine Gluconate: by Application(USD Million)
  • Table 8. Chlorhexidine Gluconate Skin Preparation , by Region USD Million (2015-2020)
  • Table 9. Chlorhexidine Gluconate Surgical Preparation , by Region USD Million (2015-2020)
  • Table 10. Chlorhexidine Gluconate Pharmaceutical Product , by Region USD Million (2015-2020)
  • Table 11. Chlorhexidine Gluconate Cosmetics Additive , by Region USD Million (2015-2020)
  • Table 12. Chlorhexidine Gluconate Others , by Region USD Million (2015-2020)
  • Table 13. Chlorhexidine Gluconate: by Form(USD Million)
  • Table 14. Chlorhexidine Gluconate Water Soluble (Digluconate, Acetate) , by Region USD Million (2015-2020)
  • Table 15. Chlorhexidine Gluconate Sparingly Soluble(Hydrochloride) , by Region USD Million (2015-2020)
  • Table 16. Chlorhexidine Gluconate: by Dosage Forms(USD Million)
  • Table 17. Chlorhexidine Gluconate Mucous membrane insert (2.5 mg) , by Region USD Million (2015-2020)
  • Table 18. Chlorhexidine Gluconate Mucous membrane liquid (0.12%) , by Region USD Million (2015-2020)
  • Table 19. South America Chlorhexidine Gluconate, by Country USD Million (2015-2020)
  • Table 20. South America Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 21. South America Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 22. South America Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 23. South America Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 24. Brazil Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 25. Brazil Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 26. Brazil Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 27. Brazil Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 28. Argentina Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 29. Argentina Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 30. Argentina Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 31. Argentina Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 32. Rest of South America Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 34. Rest of South America Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 35. Rest of South America Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 36. Asia Pacific Chlorhexidine Gluconate, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 39. Asia Pacific Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 40. Asia Pacific Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 41. China Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 42. China Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 43. China Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 44. China Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 45. Japan Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 46. Japan Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 47. Japan Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 48. Japan Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 49. India Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 50. India Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 51. India Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 52. India Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 53. South Korea Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 54. South Korea Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 55. South Korea Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 56. South Korea Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 57. Taiwan Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 58. Taiwan Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 59. Taiwan Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 60. Taiwan Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 61. Australia Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 62. Australia Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 63. Australia Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 64. Australia Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 69. Europe Chlorhexidine Gluconate, by Country USD Million (2015-2020)
  • Table 70. Europe Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 71. Europe Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 72. Europe Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 73. Europe Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 74. Germany Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 75. Germany Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 76. Germany Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 77. Germany Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 78. France Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 79. France Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 80. France Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 81. France Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 82. Italy Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 83. Italy Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 84. Italy Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 85. Italy Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 86. United Kingdom Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 88. United Kingdom Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 89. United Kingdom Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 90. Netherlands Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 91. Netherlands Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 92. Netherlands Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 93. Netherlands Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 94. Rest of Europe Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 96. Rest of Europe Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 97. Rest of Europe Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 98. MEA Chlorhexidine Gluconate, by Country USD Million (2015-2020)
  • Table 99. MEA Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 100. MEA Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 101. MEA Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 102. MEA Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 103. Middle East Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 104. Middle East Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 105. Middle East Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 106. Middle East Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 107. Africa Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 108. Africa Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 109. Africa Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 110. Africa Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 111. North America Chlorhexidine Gluconate, by Country USD Million (2015-2020)
  • Table 112. North America Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 113. North America Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 114. North America Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 115. North America Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 116. United States Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 117. United States Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 118. United States Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 119. United States Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 120. Canada Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 121. Canada Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 122. Canada Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 123. Canada Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 124. Mexico Chlorhexidine Gluconate, by Type USD Million (2015-2020)
  • Table 125. Mexico Chlorhexidine Gluconate, by Application USD Million (2015-2020)
  • Table 126. Mexico Chlorhexidine Gluconate, by Form USD Million (2015-2020)
  • Table 127. Mexico Chlorhexidine Gluconate, by Dosage Forms USD Million (2015-2020)
  • Table 128. Chlorhexidine Gluconate: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Chlorhexidine Gluconate: by Type(USD Million)
  • Table 140. Chlorhexidine Gluconate CHG 2% Solution , by Region USD Million (2021-2026)
  • Table 141. Chlorhexidine Gluconate CHG 4% Solution , by Region USD Million (2021-2026)
  • Table 142. Chlorhexidine Gluconate CHG 20% Solution , by Region USD Million (2021-2026)
  • Table 143. Chlorhexidine Gluconate CHG 0.12% Solution , by Region USD Million (2021-2026)
  • Table 144. Chlorhexidine Gluconate Others , by Region USD Million (2021-2026)
  • Table 145. Chlorhexidine Gluconate: by Application(USD Million)
  • Table 146. Chlorhexidine Gluconate Skin Preparation , by Region USD Million (2021-2026)
  • Table 147. Chlorhexidine Gluconate Surgical Preparation , by Region USD Million (2021-2026)
  • Table 148. Chlorhexidine Gluconate Pharmaceutical Product , by Region USD Million (2021-2026)
  • Table 149. Chlorhexidine Gluconate Cosmetics Additive , by Region USD Million (2021-2026)
  • Table 150. Chlorhexidine Gluconate Others , by Region USD Million (2021-2026)
  • Table 151. Chlorhexidine Gluconate: by Form(USD Million)
  • Table 152. Chlorhexidine Gluconate Water Soluble (Digluconate, Acetate) , by Region USD Million (2021-2026)
  • Table 153. Chlorhexidine Gluconate Sparingly Soluble(Hydrochloride) , by Region USD Million (2021-2026)
  • Table 154. Chlorhexidine Gluconate: by Dosage Forms(USD Million)
  • Table 155. Chlorhexidine Gluconate Mucous membrane insert (2.5 mg) , by Region USD Million (2021-2026)
  • Table 156. Chlorhexidine Gluconate Mucous membrane liquid (0.12%) , by Region USD Million (2021-2026)
  • Table 157. South America Chlorhexidine Gluconate, by Country USD Million (2021-2026)
  • Table 158. South America Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 159. South America Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 160. South America Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 161. South America Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 162. Brazil Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 163. Brazil Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 164. Brazil Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 165. Brazil Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 166. Argentina Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 167. Argentina Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 168. Argentina Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 169. Argentina Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 170. Rest of South America Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 171. Rest of South America Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 172. Rest of South America Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 173. Rest of South America Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 174. Asia Pacific Chlorhexidine Gluconate, by Country USD Million (2021-2026)
  • Table 175. Asia Pacific Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 176. Asia Pacific Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 177. Asia Pacific Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 178. Asia Pacific Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 179. China Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 180. China Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 181. China Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 182. China Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 183. Japan Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 184. Japan Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 185. Japan Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 186. Japan Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 187. India Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 188. India Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 189. India Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 190. India Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 191. South Korea Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 192. South Korea Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 193. South Korea Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 194. South Korea Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 195. Taiwan Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 196. Taiwan Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 197. Taiwan Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 198. Taiwan Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 199. Australia Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 200. Australia Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 201. Australia Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 202. Australia Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 207. Europe Chlorhexidine Gluconate, by Country USD Million (2021-2026)
  • Table 208. Europe Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 209. Europe Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 210. Europe Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 211. Europe Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 212. Germany Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 213. Germany Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 214. Germany Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 215. Germany Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 216. France Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 217. France Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 218. France Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 219. France Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 220. Italy Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 221. Italy Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 222. Italy Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 223. Italy Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 224. United Kingdom Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 225. United Kingdom Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 226. United Kingdom Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 227. United Kingdom Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 228. Netherlands Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 229. Netherlands Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 230. Netherlands Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 231. Netherlands Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 232. Rest of Europe Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 233. Rest of Europe Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 234. Rest of Europe Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 235. Rest of Europe Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 236. MEA Chlorhexidine Gluconate, by Country USD Million (2021-2026)
  • Table 237. MEA Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 238. MEA Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 239. MEA Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 240. MEA Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 241. Middle East Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 242. Middle East Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 243. Middle East Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 244. Middle East Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 245. Africa Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 246. Africa Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 247. Africa Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 248. Africa Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 249. North America Chlorhexidine Gluconate, by Country USD Million (2021-2026)
  • Table 250. North America Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 251. North America Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 252. North America Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 253. North America Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 254. United States Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 255. United States Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 256. United States Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 257. United States Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 258. Canada Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 259. Canada Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 260. Canada Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 261. Canada Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 262. Mexico Chlorhexidine Gluconate, by Type USD Million (2021-2026)
  • Table 263. Mexico Chlorhexidine Gluconate, by Application USD Million (2021-2026)
  • Table 264. Mexico Chlorhexidine Gluconate, by Form USD Million (2021-2026)
  • Table 265. Mexico Chlorhexidine Gluconate, by Dosage Forms USD Million (2021-2026)
  • Table 266. Chlorhexidine Gluconate: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Chlorhexidine Gluconate: by Type USD Million (2015-2020)
  • Figure 5. Global Chlorhexidine Gluconate: by Application USD Million (2015-2020)
  • Figure 6. Global Chlorhexidine Gluconate: by Form USD Million (2015-2020)
  • Figure 7. Global Chlorhexidine Gluconate: by Dosage Forms USD Million (2015-2020)
  • Figure 8. South America Chlorhexidine Gluconate Share (%), by Country
  • Figure 9. Asia Pacific Chlorhexidine Gluconate Share (%), by Country
  • Figure 10. Europe Chlorhexidine Gluconate Share (%), by Country
  • Figure 11. MEA Chlorhexidine Gluconate Share (%), by Country
  • Figure 12. North America Chlorhexidine Gluconate Share (%), by Country
  • Figure 13. Global Chlorhexidine Gluconate: by Type USD/Units (2015-2020)
  • Figure 14. Global Chlorhexidine Gluconate share by Players 2020 (%)
  • Figure 15. Global Chlorhexidine Gluconate share by Players (Top 3) 2020(%)
  • Figure 16. Global Chlorhexidine Gluconate share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Xttrium Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Xttrium Laboratories (United States) Revenue: by Geography 2020
  • Figure 20. Medichem (South Africa) Revenue, Net Income and Gross profit
  • Figure 21. Medichem (South Africa) Revenue: by Geography 2020
  • Figure 22. The Clorox Company (United States) Revenue, Net Income and Gross profit
  • Figure 23. The Clorox Company (United States) Revenue: by Geography 2020
  • Figure 24. Becton Dickinson Co(United States) Revenue, Net Income and Gross profit
  • Figure 25. Becton Dickinson Co(United States) Revenue: by Geography 2020
  • Figure 26. Bajaj Medical (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bajaj Medical (United States) Revenue: by Geography 2020
  • Figure 28. MölnlyckeHealth Care (Sweden) Revenue, Net Income and Gross profit
  • Figure 29. MölnlyckeHealth Care (Sweden) Revenue: by Geography 2020
  • Figure 30. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 31. 3M (United States) Revenue: by Geography 2020
  • Figure 32. Ecolab (United States) Revenue, Net Income and Gross profit
  • Figure 33. Ecolab (United States) Revenue: by Geography 2020
  • Figure 34. Sage Prods (United States) Revenue, Net Income and Gross profit
  • Figure 35. Sage Prods (United States) Revenue: by Geography 2020
  • Figure 36. STERIS (Ireland) Revenue, Net Income and Gross profit
  • Figure 37. STERIS (Ireland) Revenue: by Geography 2020
  • Figure 38. Global Chlorhexidine Gluconate: by Type USD Million (2021-2026)
  • Figure 39. Global Chlorhexidine Gluconate: by Application USD Million (2021-2026)
  • Figure 40. Global Chlorhexidine Gluconate: by Form USD Million (2021-2026)
  • Figure 41. Global Chlorhexidine Gluconate: by Dosage Forms USD Million (2021-2026)
  • Figure 42. South America Chlorhexidine Gluconate Share (%), by Country
  • Figure 43. Asia Pacific Chlorhexidine Gluconate Share (%), by Country
  • Figure 44. Europe Chlorhexidine Gluconate Share (%), by Country
  • Figure 45. MEA Chlorhexidine Gluconate Share (%), by Country
  • Figure 46. North America Chlorhexidine Gluconate Share (%), by Country
  • Figure 47. Global Chlorhexidine Gluconate: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Xttrium Laboratories (United States)
  • Medichem (South Africa)
  • The Clorox Company (United States)
  • Becton Dickinson Co(United States)
  • Bajaj Medical (United States)
  • MölnlyckeHealth Care (Sweden)
  • 3M (United States)
  • Ecolab (United States)
  • Sage Prods (United States)
  • STERIS (Ireland)
Additional players considered in the study are as follows:
Dharma Research (United States)
Select User Access Type

Key Highlights of Report


Mar 2021 226 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Chlorhexidine Gluconate Quantitative research analysis
Global Chlorhexidine Gluconate Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"The chlorhexidine gluconate is used in preoperational procedures to clean the skin and make it germ-free to ease the surgical procedure. The different advantages of chlorhexidine gluconate (CHG) cloths have increased the demand for these products globally " is seen as one of major growth factors of Chlorhexidine Gluconate Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Chlorhexidine Gluconate Report?

Have a Query? Click Here

Other Related Reports

Rosemary Extract Comprehensive Study by Type (Carnosic acid, Rosemarinic acid, Essential oil, Others), Application (Food industry (Sauces, Dressings, and Condiments, Bakery and Confectionery, Dairy P...
$ 3750
ePharmacy - Comprehensive Study by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss, Others), Drug Type (Prescription Drugs, Over The Counter (OTC) Drugs) Players and Region - Global Mark...
$ 3500
Capillary Blood Collection Tubes Comprehensive Study by Type (Plastic Blood Collection Tubes, Glass Blood Collection Tubes, Stainless Steel Blood Collection Tubes, Ceramic Blood Collection Tubes), Ap...
$ 3800
Porcine Vaccines Comprehensive Study by Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), Application (Swine Fever Vaccin...
$ 3450
Endocrinology Drugs Comprehensive Study by Type (Diabetic Aagents, Hormone Agonists, Hormone Antagonists), Drug (Prescription Drugs, Over-the-counter Drugs), End User (Hospitals, Commercial Laborator...
$ 3350
Cancer Supportive Care Products Comprehensive Study by Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), Distrib...
$ 3750